Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment

BACKGROUND: An early virological response (EVR) after the start of interferon (IFN) treatment for chronic hepatitis C leads to a successful virological outcome. To analyze an association between sustained virological response (SVR) and EVR by comparing TaqMan with Amplicor assays in HCV genotype 1-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Eiichi, Furusyo, Norihiro, Toyoda, Kazuhiro, Taniai, Hiroaki, Otaguro, Shigeru, Kainuma, Mosaburo, Murata, Masayuki, Sawayama, Yasunori, Hayashi, Jun
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873600/
https://www.ncbi.nlm.nih.gov/pubmed/20398383
http://dx.doi.org/10.1186/1471-230X-10-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873600/
https://www.ncbi.nlm.nih.gov/pubmed/20398383
http://dx.doi.org/10.1186/1471-230X-10-38

Ejemplares similares